Assessment of 18F-DCFPyL PSMA PET/CT and PET/MR quantitative parameters for reference standard organs: Inter-reader, inter-modality, and inter-patient variability

• Published in: PloS one Vol. 18; no. 4; p. e0283830
• Main Authors: Lawrence, Edward M, Kieler, Minnie, Cooley, Greg, Wells, Shane A, Cho, Steve Y
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 06-04-2023; Public Library of Science (PLoS)
• Subjects: Agreements; Androgens; Antigens; Bias; Biology and Life Sciences; Blood; Cancer therapies; Evaluation; Exocrine glands; Fluorine isotopes; Humans; Liver; Liver - diagnostic imaging; Male; Medicine and Health Sciences; Metastasis; Middle Aged; Organs; Parotid gland; Patients; Positron emission tomography; Positron Emission Tomography Computed Tomography; Prostate cancer; Prostatic Neoplasms - diagnostic imaging; Quantitation; Radiation therapy; Radioactive tracers; Reference Standards; Research and Analysis Methods; Salivary glands; Statistical analysis; Thermometers; Tracers; Variability
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0283830

Prostate specific membrane antigen (PSMA)-based radiotracers have shown promise for prostate cancer assessment. Evaluation of quantitative variability and establishment of reference standards are important for optimal clinical and research utility. This work evaluates the variability of PSMA-based [18F]DCFPyL (PyL) PET quantitative reference standards. Consecutive eligible patients with biochemically recurrent prostate cancer were recruited for study participation from August 2016-October 2017. After PyL tracer injection, whole body PET/CT (wbPET/CT) was obtained with subsequent whole body PET/MR (wbPET/MR). Two readers independently created regions of interest (ROIs) including a 40% standardized uptake value (SUV) threshold ROI of the whole right parotid gland and separate spherical ROIs in the superior, mid, and inferior gland. Additional liver (right lobe) and blood pool spherical ROIs were defined. Bland-Altman analysis, including limits of agreement (LOA), as well as interquartile range (IQR) and coefficient of variance (CoV) was used. Twelve patients with prostate cancer were recruited (mean age, 61.8 yrs; range 54-72 years). One patient did not have wbPET/MR and was excluded. There was minimal inter-reader SUVmean variability (bias±LOA) for blood pool (-0.13±0.42; 0.01±0.41), liver (-0.55±0.82; -0.22±1.3), or whole parotid gland (-0.05±0.31; 0.08±0.24) for wbPET/CT and wbPET/MR, respectively. Greater inter-reader variability for the 1-cm parotid gland ROIs was present, for both wbPET/CT and wbPET/MR. Comparing wbPET/CT to the subsequently acquired wbPET/MR, blood pool had a slight decrease in SUVmean. The liver as well as parotid gland showed a slight increase in activity although the absolute bias only ranged from 0.45-1.28. The magnitude of inter-subject variability was higher for the parotid gland regardless of modality or reader. In conclusion, liver, blood pool, and whole parotid gland quantitation show promise as reliable reference normal organs for clinical/research PET applications. Variability with 1-cm parotid ROIs may limit its use.